Howard G. Welgus
Director at Arcutis Biotherapeutics, Inc. (ARQT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 4,73035,841 held (−12%) | $24.18 | $114K | +9.9% |
| Aug 19SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 4,73036,475 held (−11%) | $26.18 | $124K | +1.5% |
| Jul 17SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 4,73037,109 held (−11%) | $26.91 | $127K | -1.2% |
| Jun 17SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 4,09638,378 held (−10%) | $24.41 | $100K | +8.9% |
| Jun 17SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 63537,743 held (−2%) | $25.67 | $16K | +3.5% |
| May 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 7,14432,600 held (−18%) | $22.99 | $164K | +15.6% |
| Apr 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 10,00039,744 held (−20%) | $23.88 | $239K | +11.3% |
| Mar 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 10,00049,744 held (−17%) | $25.65 | $256K | +3.6% |
| Feb 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 10,00059,744 held (−14%) | $25.05 | $250K | +6.1% |
| Jan 6SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 10,00069,744 held (−13%) | $28.96 | $290K | -8.2% |
| Dec 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 10,00079,744 held (−11%) | $30.21 | $302K | -12.0% |
| Nov 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 10,00089,744 held (−10%) | $25.27 | $253K | +5.2% |
| Oct 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 9,538100,206 held (−9%) | $18.92 | $180K | +40.5% |
| Oct 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 46299,744 held (−0%) | $18.92 | $9K | +40.5% |
- Sell
Director Howard G. Welgus sold $114K of ARQT at $24.18 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Howard G. Welgus sold $124K of ARQT at $26.18 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Howard G. Welgus sold $127K of ARQT at $26.91 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Howard G. Welgus sold $100K of ARQT at $24.41 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Howard G. Welgus sold $16K of ARQT at $25.67 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Howard G. Welgus sold $164K of ARQT at $22.99 — pre-scheduled 10b5-1 plan sale.